Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Mesothelioma × Zoledronic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Breast Neoplasms 31 Prostatic Neoplasms 18 Neoplasm Metastasis 13 Multiple Myeloma 13 Osteoporosis 8 Osteosarcoma 5 Neuroblastoma 5 Carcinoma, Non-Small-Cell Lung 5 Pain 4 Lung Neoplasms 4 Carcinoma, Renal Cell 4 Sarcoma, Ewing 3 Neoplasms, Plasma Cell 3 Neoplasms 3 Bone Diseases, Metabolic 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rhabdomyosarcoma 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Osteonecrosis 2 Myelodysplastic Syndromes 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Kidney Neoplasms 2 Humoral Hypercalcemia Of Malignancy 2 Carcinoma, Hepatocellular 2 Breast Neoplasms, Male 2 Adenocarcinoma 2 With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer 1 Uterine Cervical Dysplasia 1

Interventions

Pemetrexed 20 Cisplatin 17 Nivolumab 7 Gemcitabine 7 Carboplatin 7 durvalumab 5 Radiotherapy, Intensity-Modulated 4 Ipilimumab 4 Bevacizumab 4 tremelimumab 3 pembrolizumab 3 niraparib 3 Cerebral Decortication 3 Blood Specimen Collection 3 sargramostim 2 Thoracoscopy 2 Surveys and Questionnaires 2 Sorafenib 2 Radiosurgery 2 Oxaliplatin 2 Magnesium Sulfate 2 Leucovorin 2 Imatinib Mesylate 2 Drug Therapy 2 Doxorubicin 2 Dexamethasone 2 Cyclophosphamide 2 sodium thiosulfate 1 pevonedistat 1 perflutren 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01204203 2017-05-24

UAB0901

University of Alabama at Birmingham

Phase 2 Completed

8 enrolled 5 charts

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡